Patient-derived Glioma Stem Cell Organoids
Primary and study completion pushed from Sep 1, 2025 to Jan 1, 2027
Maastricht Radiation OncologyNot specified NCT04868396 Registry history of NCT04868396 on ClinicalTrials.gov (opens the registry)
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
Primary and study completion pushed from Sep 1, 2025 to Jan 1, 2027
Maastricht Radiation OncologyNot specified NCT04868396 Registry history of NCT04868396 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Maastricht Radiation OncologyNot specified NCT07501845 Registry history of NCT07501845 on ClinicalTrials.gov (opens the registry)
Trial completed
Maastricht Radiation OncologyNot specified NCT04655469 Registry history of NCT04655469 on ClinicalTrials.gov (opens the registry)
Trial completed
Maastricht Radiation OncologyNot specified NCT05565313 Registry history of NCT05565313 on ClinicalTrials.gov (opens the registry)
Lung Cancer (4) · Colorectal Cancer (3) · Glioma (3) · Non-Small Cell Lung Cancer (NSCLC) (2) · Breast Cancer (1) · Epilepsy (1) · Glioblastoma (1) · Head & Neck Cancer (1) · Prostate Cancer (1)